DOCSLIB.ORG

International Narcotics Control Strategy Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International Narcotics Control Strategy Report United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2020 INCSR 2020 Volume 1 Table of Contents Table of Contents Common Abbreviations .......................................................................................................................................... iii International Agreements .......................................................................................................................................... v INTRODUCTION ........................................................................................................................................... 1 Legislative Basis for the INCSR ............................................................................................................................... 2 Presidential Determination ........................................................................................................................................ 7 Policy and Program Developments ......................................................................................................... 12 Overview ................................................................................................................................................................. 13 Methodology for U.S. Government Estimates of Illegal Drug Production ............................................................. 18 Parties to UN Conventions ...................................................................................................................................... 24 (with dates ratified/acceded) ................................................................................................................................... 24 USG Assistance ........................................................................................................................................ 30 International Training .............................................................................................................................................. 32 Drug Enforcement Administration (DEA) .............................................................................................................. 35 United States Coast Guard (USCG) ........................................................................................................................ 38 U.S. Customs and Border Protection (CBP) ............................................................................................................ 40 Chemical Controls .................................................................................................................................... 44 Synthetic Drugs ......................................................................................................................................... 80 Country Reports ........................................................................................................................................ 90 Afghanistan ............................................................................................................................................................. 91 Albania .................................................................................................................................................................... 94 Algeria ..................................................................................................................................................................... 95 Argentina ................................................................................................................................................................. 96 The Bahamas ........................................................................................................................................................... 97 Belgium ................................................................................................................................................................. 100 Belize..................................................................................................................................................................... 101 Benin ..................................................................................................................................................................... 104 Bolivia ................................................................................................................................................................... 105 Brazil ..................................................................................................................................................................... 109 Burma .................................................................................................................................................................... 112 Cabo Verde ............................................................................................................................................................ 116 Canada ................................................................................................................................................................... 117 China ..................................................................................................................................................................... 118 Colombia ............................................................................................................................................................... 122 Costa Rica ............................................................................................................................................................. 125 Cuba ...................................................................................................................................................................... 129 Dominican Republic .............................................................................................................................................. 130 Dutch Caribbean .................................................................................................................................................... 133 Eastern Caribbean ................................................................................................................................................. 136 Ecuador ................................................................................................................................................................. 139 El Salvador ............................................................................................................................................................ 143 Georgia .................................................................................................................................................................. 146 Ghana .................................................................................................................................................................... 147 Guatemala ............................................................................................................................................................. 150 Guyana .................................................................................................................................................................. 154 Haiti ....................................................................................................................................................................... 157 Honduras ............................................................................................................................................................... 160 India....................................................................................................................................................................... 164 i INCSR 2020 Volume 1 Table of Contents Indonesia ............................................................................................................................................................... 168 Iran ........................................................................................................................................................................ 171 Jamaica .................................................................................................................................................................. 172 Kazakhstan ............................................................................................................................................................ 175 Kenya .................................................................................................................................................................... 178 Kyrgyz Republic ................................................................................................................................................... 181 Laos ....................................................................................................................................................................... 184 Liberia ................................................................................................................................................................... 187 Malaysia ...............................................................................................................................................................
Load more

Recommended publications
  • Customs Act (Republic of Korea)
    Customs Act (Republic of Korea) By Ministry of Legislation INTRODUCTION Details of Enactment and Amendment ● Enactment: The Customs Act was enacted in 1949, and after being amended over more than 35 occasions, wholly amended in the year of 2000, and then partly amended in the year of 2002. This Act provides not only the regulatory details on the imposition and collection of customs, but also the matters concerning the overall customs administrative details, such as the taxpayer's right and procedure for filing objections, bonded area, clearance procedures, and punishment of customs criminals, etc. ● Amendment: The recent amendments of the Customs Act have been made in the year of 1998, 1999, 2000 and 2002, and such amendments are meant to improve the bond systems in order to induce foreign investments, to simplify the appeal procedures against the imposition of customs, and to strengthen the guarantee of duty payer's right by enacting the Charter of Duty Payer's Rights. The grounds for TSG (Transitional Safeguard) against China are newly established according to the joining of China in WTO, the e-delivery system and the system of designation of e-document brokerage operator are newly introduced to implement e-government, and the requirements for the return of travelers' personal effects excessively carried in are strengthened to restrict indiscreet shipping-in of personal effects. Main Contents ● The customs are imposed in principle based on the time of import declaration, but their tax rates are separately stipulated in the Tariff Schedule: Provided, That the simple customs are imposed on personal effect, mail, and consignment.
    [Show full text]
  • Report of the International Narcotics Control Board for 2020 (E/INCB/2020/1) Is Supplemented by the Following Reports
    INTERNATIONAL NARCOTICS CONTROL BOARD Report 2020 EMBARGO Observe release date: Not to be published or broadcast before Thursday 25 March 2021, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board for 2020 TheReport of the International Narcotics Control Board for 2020 (E/INCB/2020/1) is supplemented by the following reports: Celebrating 60 Years of the Single Convention on Narcotic Drugs of 1961 and 50 Years of the Convention on Psychotropic Substances of 1971 (E/INCB/2020/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2021 — Statistics for 2019 (E/INCB/2020/2) Psychotropic Substances: Statistics for 2019 — Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Sub- stances of 1971 (E/INCB/2020/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psycho tropic Substances: Report of the International Narcotics Control Board for 2020 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2020/4) The updated lists of substances under international control, comprising narcotic drugs, psycho­ tropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E­1339 P.O.
    [Show full text]
  • Genetic Analysis of the Major Tribes of Buner and Swabi Areas Through Dental Morphology and Dna Analysis
    GENETIC ANALYSIS OF THE MAJOR TRIBES OF BUNER AND SWABI AREAS THROUGH DENTAL MORPHOLOGY AND DNA ANALYSIS MUHAMMAD TARIQ DEPARTMENT OF GENETICS HAZARA UNIVERSITY MANSEHRA 2017 I HAZARA UNIVERSITY MANSEHRA Department of Genetics GENETIC ANALYSIS OF THE MAJOR TRIBES OF BUNER AND SWABI AREAS THROUGH DENTAL MORPHOLOGY AND DNA ANALYSIS By Muhammad Tariq This research study has been conducted and reported as partial fulfillment of the requirements of PhD degree in Genetics awarded by Hazara University Mansehra, Pakistan Mansehra The Friday 17, February 2017 I ABSTRACT This dissertation is part of the Higher Education Commission of Pakistan (HEC) funded project, “Enthnogenetic elaboration of KP through Dental Morphology and DNA analysis”. This study focused on five major ethnic groups (Gujars, Jadoons, Syeds, Tanolis, and Yousafzais) of Buner and Swabi Districts, Khyber Pakhtunkhwa Province, Pakistan, through investigations of variations in morphological traits of the permanent tooth crown, and by molecular anthropology based on mitochondrial and Y-chromosome DNA analyses. The frequencies of seven dental traits, of the Arizona State University Dental Anthropology System (ASUDAS) were scored as 17 tooth- trait combinations for each sample, encompassing a total sample size of 688 individuals. These data were compared to data collected in an identical fashion among samples of prehistoric inhabitants of the Indus Valley, southern Central Asia, and west-central peninsular India, as well as to samples of living members of ethnic groups from Abbottabad, Chitral, Haripur, and Mansehra Districts, Khyber Pakhtunkhwa and to samples of living members of ethnic groups residing in Gilgit-Baltistan. Similarities in dental trait frequencies were assessed with C.A.B.
    [Show full text]
  • Collection of Statutes and Regulations on Combating Illicit Trafficking of Narcotic Drugs
    CARICC’s Capacities in Assisting to Combat Transnational Drug-Related Crime A goal of establishment and primary objectives of CARICC Goal – to coordinate efforts of competent authorities of member- states in combating illicit drug trafficking. Primary objectives: ► to assist in organizing and coordinating joint international operations to combat transnational drug-related crime; ► collecting, storing, protecting, analyzing, and information sharing on drug- related crime. CARICC member-states shall determine National Coordinating and Competent Authorities, which interact with the Center. Observers with CARICC: Austria Afghanistan Great Britain Germany Italy Canada China Pakistan Romania U.S.A. Turkey Ukraine France Finland INTERPOL SELEC Example of CARICC’s assistance with coordinating a controlled delivery Initiator of the CUSTOMS SERVICE Opearation OF KYRGYZSTAN Coordinator of the Operation CUSTOMS SECURITY MINISTRY OF SERVICE OF SERVICE OF INTERNAL AFFAIRS RUSSIA UKRAINE OF UKRAINE Participants to the Operation A route and results of the controlled delivery Two citizens of Lithuania and four citizens of Latvia were arrested; the entire controlled cargo was seized - 2 kg of heroin. Москва Ирландия Киев The final destination point of drugs was identified. Бишкек Also, the involvement of the members of DTO in the smuggling of cigarettes, where also heroin was concealed, from Ukraine to Ireland has been indentified. Results of collection of information using CARICC capacities : With the assistance of CARICC, links of an organizer of the
    [Show full text]
  • 2020 International Narcotics Control Strategy Report
    United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2020 INCSR 2020 Volume 1 Table of Contents Table of Contents Common Abbreviations ..................................................................................................................................... iii International Agreements.................................................................................................................................... v INTRODUCTION ..................................................................................................................................... 1 Legislative Basis for the INCSR ......................................................................................................................... 2 Presidential Determination ................................................................................................................................. 7 Policy and Program Developments .................................................................................................... 12 Overview ......................................................................................................................................................... 13 Methodology for U.S. Government Estimates of Illegal Drug Production .......................................................... 18 Parties to UN Conventions ..............................................................................................................................
    [Show full text]
  • Report of the International Narcotics Control Board for 2020
    78 INCB REPORT 2020 550. Taking note of the heavy toll that the COVID-19 The Board has repeatedly expressed its concerns over pandemic has had on the most vulnerable sectors of serious human rights violations, especially with regard to society, especially people suffering from drug use extrajudicial actions, committed in purported pursuit of disorders, Argentina and Uruguay developed action plans drug control objectives. These violations contravene to assist those populations. In Argentina, the Secretariat internationally recognized human rights standards and for Comprehensive Drug Policies activated a contingency are inconsistent with the obligations of Governments plan to guarantee the provision of essential services under the three international drug control conventions. through community structures and call centres that are available 24 hours a day, seven days a week. In Uruguay, the National Drug Board started the implementation of 1. Major developments Project Paradores, which offers places in daytime shelters to people living on the street who have a high risk of 552. More than any other part of the world, the coun- marginalization and social exclusion. National data from tries in East and South-East Asia continue to see an Uruguay show that 87 per cent of its citizens living on the increase in the illicit manufacture of, trafficking in and streets consume some type of illicit drug. As such, Project use of synthetic drugs, in particular methamphetamine. Paradores has been promoted as part of a comprehensive The price of methamphetamine decreased to its lowest in initiative: while focusing on the prevention and containment a decade, while purity remained stable or increased.
    [Show full text]
  • Exposures Associated with Clandestine Methamphetamine Drug Laboratories in Australia
    Rev Environ Health 2016; 31(3): 329–352 Jackie Wright*, John Edwards and Stewart Walker Exposures associated with clandestine methamphetamine drug laboratories in Australia DOI 10.1515/reveh-2016-0017 Received April 20, 2016; accepted June 7, 2016; previously published Introduction online July 18, 2016 Illicit drugs such as amphetamine-type stimulants (ATS) Abstract: The clandestine manufacture of methamphet- (1) are manufactured in Australia within clandestine amine in residential homes may represent significant laboratories that range from crude, makeshift operations hazards and exposures not only to those involved in the using simple processes to sophisticated operations. These manufacture of the drugs but also to others living in the laboratories use a range of chemical precursors to manu- home (including children), neighbours and first respond- facture or “cook” ATS that include methylamphetamine, ers to the premises. These hazards are associated with more commonly referred to as methamphetamine (“ice”) the nature and improper storage and use of precursor and 3,4-methylenedioxymethamphetamine (MDMA or chemicals, intermediate chemicals and wastes, gases and “ecstasy”). In Australia the primary ATS manufactured methamphetamine residues generated during manufac- in clandestine drug laboratories is methamphetamine ture and the drugs themselves. Many of these compounds (2), which is the primary focus of this review. Clandes- are persistent and result in exposures inside a home not tine laboratories are commonly located within residential only during manufacture but after the laboratory has been homes, units, hotel rooms, backyard sheds and cars, with seized or removed. Hence new occupants of buildings for- increasing numbers detected in Australia each year (744 merly used to manufacture methamphetamine may be laboratories detected in 2013–2014) (2).
    [Show full text]
  • Nitrosamines EMEA-H-A5(3)-1490
    25 June 2020 EMA/369136/2020 Committee for Medicinal Products for Human Use (CHMP) Assessment report Procedure under Article 5(3) of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products Procedure number: EMEA/H/A-5(3)/1490 Note: Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ...................................................................................... 2 1. Information on the procedure ............................................................... 7 2. Scientific discussion .............................................................................. 7 2.1. Introduction......................................................................................................... 7 2.2. Quality and safety aspects ..................................................................................... 7 2.2.1. Root causes for presence of N-nitrosamines in medicinal products and measures to mitigate them............................................................................................................. 8 2.2.2. Presence and formation of N-nitrosamines
    [Show full text]
  • Page 498 TITLE 21—FOOD AND
    § 695 TITLE 21—FOOD AND DRUGS Page 498 pealed the permanent appropriation under the title Sec. ‘‘Meat inspection, Bureau of Animal Industry (fiscal 822. Persons required to register. year) (3–114)’’ effective July 1, 1935, provided that such 823. Registration requirements. portions of any Acts as make permanent appropriations 824. Denial, revocation, or suspension of registra- to be expended under such account are amended so as tion. to authorize, in lieu thereof, annual appropriations 825. Labeling and packaging. from the general fund of the Treasury in identical 826. Production quotas for controlled substances. terms and in such amounts as now provided by the laws 827. Records and reports of registrants. providing such permanent appropriations, and author- 828. Order forms. ized, in addition thereto, the appropriation of ‘‘such 829. Prescriptions. other sums as may be necessary in the enforcement of 830. Regulation of listed chemicals and certain the meat inspection laws.’’ In the original, the par- machines. enthetical ‘‘(U.S.C., title 21, secs. 71 to 96, inclusive)’’ 831. Additional requirements relating to online followed the phrase ‘‘meat inspection laws’’. The ‘‘meat pharmacies and telemedicine. inspection laws’’ are classified generally to this chap- ter. PART D—OFFENSES AND PENALTIES Section was not enacted as part of the Federal Meat 841. Prohibited acts A. Inspection Act which is classified to subchapters I to 842. Prohibited acts B. IV–A of this chapter. 843. Prohibited acts C. Section was formerly classified to section 95 of this 844. Penalties for simple possession. title. 844a. Civil penalty for possession of small amounts § 695. Payment of cost of meat-inspection service; of certain controlled substances.
    [Show full text]
  • Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function S
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2016/08/03/jpet.116.234781.DC1 1521-0103/359/1/134–141$25.00 http://dx.doi.org/10.1124/jpet.116.234781 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 359:134–141, October 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function s Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat, and Aditi Das Department of Chemistry (J.R.), Division of Nutritional Sciences, Departments of Comparative Biosciences, Biochemistry, and Bioengineering, Center for Biophysics and Quantitative Biology, Beckman Institute for Advanced Science (A.D.), University of Illinois at Urbana-Champaign, Urbana, Illinois; Division of Cardiovascular Medicine (M.H.), Department of Pharmacology (R.A., M.H.), University of Michigan Medical School, Ann Arbor, Michigan; and Department of Internal Medicine, Texas Health Science Center, McGovern Medical School, Houston, Texas (R.K.) Received April 27, 2016; accepted August 1, 2016 Downloaded from ABSTRACT The inhibition of platelet aggregation is key to preventing particular, the aspirin-DHA anhydride displayed similar effective- conditions such as myocardial infarction and ischemic stroke. ness to aspirin. Platelet aggregation studies conducted in the Aspirin is the most widely used drug to inhibit platelet aggre- presence of various platelet agonists indicated that the aspirin-lipid gation. Aspirin absorption can be improved further to increase conjugates act through inhibition of the cyclooxygenase (COX)– jpet.aspetjournals.org its permeability across biologic membranes via esterification thromboxane synthase (TXAS) pathway.
    [Show full text]
  • Autochthonous Aryans? the Evidence from Old Indian and Iranian Texts
    Michael Witzel Harvard University Autochthonous Aryans? The Evidence from Old Indian and Iranian Texts. INTRODUCTION §1. Terminology § 2. Texts § 3. Dates §4. Indo-Aryans in the RV §5. Irano-Aryans in the Avesta §6. The Indo-Iranians §7. An ''Aryan'' Race? §8. Immigration §9. Remembrance of immigration §10. Linguistic and cultural acculturation THE AUTOCHTHONOUS ARYAN THEORY § 11. The ''Aryan Invasion'' and the "Out of India" theories LANGUAGE §12. Vedic, Iranian and Indo-European §13. Absence of Indian influences in Indo-Iranian §14. Date of Indo-Aryan innovations §15. Absence of retroflexes in Iranian §16. Absence of 'Indian' words in Iranian §17. Indo-European words in Indo-Iranian; Indo-European archaisms vs. Indian innovations §18. Absence of Indian influence in Mitanni Indo-Aryan Summary: Linguistics CHRONOLOGY §19. Lack of agreement of the autochthonous theory with the historical evidence: dating of kings and teachers ARCHAEOLOGY __________________________________________ Electronic Journal of Vedic Studies 7-3 (EJVS) 2001(1-115) Autochthonous Aryans? 2 §20. Archaeology and texts §21. RV and the Indus civilization: horses and chariots §22. Absence of towns in the RV §23. Absence of wheat and rice in the RV §24. RV class society and the Indus civilization §25. The Sarasvatī and dating of the RV and the Bråhmaas §26. Harappan fire rituals? §27. Cultural continuity: pottery and the Indus script VEDIC TEXTS AND SCIENCE §28. The ''astronomical code of the RV'' §29. Astronomy: the equinoxes in ŚB §30. Astronomy: Jyotia Vedåga and the
    [Show full text]
  • Building a Single Window Environment Writing a Business Case for Single Window
    VOL 2 BUILDING A SINGLE WINDOW ENVIRONMENT WRITING A BUSINESS CASE FOR SINGLE WINDOW P A R T I VOL 2 Volume 2 Part I Writing a Business Case for Single Window The business case answers the most important questions concerning the Single Window: What kind of Single Window will be built? Why will it be built? (In other words, who will benefit from it, by when and by how much?) How will it be built and who will build it? How much will it cost and who will pay for it? And how and by when will we know if it provides any benefit at all? Contents 1. Introduction ...................................................................................................................................... 3 1.1 Relationship to other Parts of the Compendium ........................................................................ 3 1.2 How is this Part Organized? ...................................................................................................... 3 2. The Need for a Business Case ......................................................................................................... 5 2.1 What is a Business Case? ........................................................................................................... 5 2.2 Collaboration is Vital .................................................................................................................. 6 3. The Strategic Business Case ........................................................................................................ 7 3.1 Economic Rationale and Strategic Value
    [Show full text]